FDA — authorised 12 January 1972
- Application: NDA016851
- Marketing authorisation holder: ABBVIE
- Local brand name: FML
- Indication: SUSPENSION/DROPS — OPHTHALMIC
- Status: approved
FDA authorised Fluorometholone 1% topical ocular steroid on 12 January 1972
Yes. FDA authorised it on 12 January 1972; FDA authorised it on 4 September 1985.
ABBVIE holds the US marketing authorisation.